Biomarker for diagnosing the risk of developing cardiovascular diseases
Posted in the Cardiology Forum
#1 Aug 8, 2011
A recent international patent application describes a method of determining the risk of developing cardiovascular disease in a patient by taking a blood sample from a patient and determining the level of leucine-rich alpha-2-glycoprotein (LRG), in the sample. An elevated or reduced level of LRG, in comparison to a control, indicates the pre-disposition to develop cardiovascular disease. News link: http://www.sciclips.com/sciclips/biomarker-ne...
Add your comments below
|I had 2 different EKG's in one week...||Oct 14||CBaz||1|
|Mycotic coronary aneurysm||Oct 12||T K Kremer Hovinga||2|
|12-Lead ECG||Sep 30||ECEJG||1|
|CABG in ITP||Sep '16||Kamala||1|
|Athlete's Heart with Myocarditis or Hypertrophi...||Sep '16||caters||1|
|a free cardiology e-book online,||Sep '16||Georgios Chatziat...||1|
Find what you want!
Search Cardiology Forum Now
Copyright © 2016 Topix LLC